Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

Jing Zhang,1,2,* Jinying Li,3 Chenjing Zhu,1 Yanlin Song,1 Fan Xia,1 Xuelei Ma1,* 1Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy, 2Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 3The Second Affiliated Hospital of Medical College of...

Full description

Bibliographic Details
Main Authors: Zhang J, Li J, Zhu C, Song Y, Xia F, Ma X
Format: Article
Language:English
Published: Dove Medical Press 2017-11-01
Series:Drug Design, Development and Therapy
Subjects:
trastuzumab emtansine
pertuzumab
human epidermal growth factor receptor 2
breast cancer
adverse events
efficacy
Online Access:https://www.dovepress.com/safety-and-efficacy-of-the-addition-of-pertuzumab-to-t-dm1-plusminus-t-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/safety-and-efficacy-of-the-addition-of-pertuzumab-to-t-dm1-plusminus-t-peer-reviewed-article-DDDT

Similar Items